These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 17495451

  • 21. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M, Wada Y, Kanazawa N, Tachibana S, Suzuki T, Matsumoto K, Iyoda M, Honda H, Shibata T.
    PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
    [Abstract] [Full Text] [Related]

  • 22. IgA nephropathy: current views of immune complex formation.
    Mestecky J, Suzuki H, Yanagihara T, Moldoveanu Z, Tomana M, Matousovic K, Julian BA, Novak J.
    Contrib Nephrol; 2007; 157():56-63. PubMed ID: 17495438
    [Abstract] [Full Text] [Related]

  • 23. O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.
    Novak J, King RG, Yother J, Renfrow MB, Green TJ.
    Glycobiology; 2024 Sep 30; 34(11):. PubMed ID: 39095059
    [Abstract] [Full Text] [Related]

  • 24. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec 30; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 25. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
    Narita I, Gejyo F.
    Clin Exp Nephrol; 2008 Oct 30; 12(5):332-338. PubMed ID: 18404247
    [Abstract] [Full Text] [Related]

  • 26. IgA glycosylation and immune complex formation in IgAN.
    Suzuki H, Novak J.
    Semin Immunopathol; 2021 Oct 30; 43(5):669-678. PubMed ID: 34570260
    [Abstract] [Full Text] [Related]

  • 27. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 28. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr 29; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 29. IgA myeloma presenting as Henoch-Schönlein purpura with nephritis.
    Zickerman AM, Allen AC, Talwar V, Olczak SA, Brownlee A, Holland M, Furness PN, Brunskill NJ, Feehally J.
    Am J Kidney Dis; 2000 Sep 29; 36(3):E19. PubMed ID: 10977812
    [Abstract] [Full Text] [Related]

  • 30. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
    Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J.
    J Clin Invest; 2009 Jun 29; 119(6):1668-77. PubMed ID: 19478457
    [Abstract] [Full Text] [Related]

  • 31. IgA nephropathy: an update.
    Julian BA, Novak J.
    Curr Opin Nephrol Hypertens; 2004 Mar 29; 13(2):171-9. PubMed ID: 15202611
    [Abstract] [Full Text] [Related]

  • 32. Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
    Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M.
    Kidney Int; 2002 Aug 29; 62(2):465-75. PubMed ID: 12110007
    [Abstract] [Full Text] [Related]

  • 33. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Aug 29; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 34. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 35. Binding sites for carrier-immobilized carbohydrates in the kidney: implication for the pathogenesis of Henoch-Schönlein purpura and/or IgA nephropathy.
    Sedivá A, Smetana K, Stejskal J, Bartůnková J, Liu FT, Bovin NV, Gabius HJ.
    Nephrol Dial Transplant; 1999 Dec 11; 14(12):2885-91. PubMed ID: 10570092
    [Abstract] [Full Text] [Related]

  • 36. Murine Models of Human IgA Nephropathy.
    Suzuki H, Suzuki Y.
    Semin Nephrol; 2018 Sep 11; 38(5):513-520. PubMed ID: 30177023
    [Abstract] [Full Text] [Related]

  • 37. Immune complexes in acute adult-onset Henoch-Schonlein nephritis.
    Hilhorst M, van Paassen P, van Breda Vriesman P, Cohen Tervaert JW.
    Nephrol Dial Transplant; 2011 Dec 11; 26(12):3960-7. PubMed ID: 21441402
    [Abstract] [Full Text] [Related]

  • 38. Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis.
    Hisano S, Matsushita M, Fujita T, Iwasaki H.
    Am J Kidney Dis; 2005 Feb 11; 45(2):295-302. PubMed ID: 15685507
    [Abstract] [Full Text] [Related]

  • 39. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Sadaka C, Leroy V, Benhamou M, Novak J, Vrtovsnik F, Haddad E, Chintalacharuvu KR, Monteiro RC.
    J Am Soc Nephrol; 2004 Mar 11; 15(3):622-34. PubMed ID: 14978164
    [Abstract] [Full Text] [Related]

  • 40. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.
    Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, Cook HT, Pickering MC, Wuhrer M, Falchi M.
    J Am Soc Nephrol; 2021 Oct 11; 32(10):2455-2465. PubMed ID: 34127537
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.